CohBar, Inc. to Announce 2015 Fourth Quarter Financial Results and Host Conference Call for Shareholders on March 9, 2016
Menlo Park, California – February 24, 2016 – CohBar, Inc. (OTCQX: CWBR and TSXV: COB.U), an innovative biotechnology company focused on developing mitochondria-based therapeutics (MBTs) to treat diseases associated with aging, will release its 2015 fourth quarter financial results on Wednesday, March 9, 2016, and will host a call for shareholders the same day at 2:00 p.m. (PST).
Shareholder Conference Call Information:
Date: March 9, 2016
Time: 2:00 p.m. (PST)
Dial-in U.S. and Canada: (888) 430-8694
Dial-in International: (719) 325-2376
Conference ID# 9496551
An audio recording of the call will be available beginning 4:00 p.m. (PST) on March 9, 2016, through 9:00 p.m. (PDT) on March 16, 2016. To access the recording please dial (877) 870-5176 in the U.S. and Canada or (858) 384-5517 internationally and reference Conference ID# 9496551.
CohBar (OTCQX: CWBR and TSXV: COB.U) is a leader in the research and development of mitochondria-based therapeutics, an emerging class of drugs for the treatment of diseases associated with aging. MBTs originate from the discovery of a novel group of peptides within the genome of mitochondria, the powerhouses of the cell. This groundbreaking discovery was made by our founders, world leaders in the biology of aging, metabolism and mitochondrial genomics. MBTs offer the potential to address a broad range of diseases such as type 2 diabetes, cancer, atherosclerosis and neurodegenerative disorders.
For additional company information, please visit www.cohbar.com.
Jeff Biunno, CFO
MacDougall Biomedical Communications